This announcement is a separate document:
Creative Medical Technology | PRER14A: Preliminary revised proxy soliciting materials
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
18:15
Swire repurchased 0.18 million B shares for 2 million HKD on December 23.
SWRAY-0.04%
18:13
Three departments: Strictly govern and rectify issues such as land occupation and chaotic use of arable land.
18:10
STELLANTIS - The Maserati brand has appointed MAURIZIO ZUARES as the new Chief Business Officer of ERFFECT, effective January 1, 2025.